Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Susan Ingram to Analgesics, Opioid

This is a "connection" page, showing publications Susan Ingram has written about Analgesics, Opioid.

 
Connection Strength
 
 
 
3.340
 
  1. Akumwami S, Ingram SL. Deciphering the opioid code. Cell Chem Biol. 2025 Dec 18; 32(12):1429-1431.
    View in: PubMed
    Score: 0.502
  2. McPherson KB, Bouchet CA, Coutens B, Ingram SL. Persistent inflammation selectively activates opioid-sensitive phasic-firing neurons within the vlPAG. J Neurophysiol. 2023 05 01; 129(5):1237-1248.
    View in: PubMed
    Score: 0.417
  3. Ingram SL. Toward understanding the opioid paradox: cellular mechanisms of opioid-induced hyperalgesia. Neuropsychopharmacology. 2022 01; 47(2):427-428.
    View in: PubMed
    Score: 0.377
  4. Macey TA, Bobeck EN, Suchland KL, Morgan MM, Ingram SL. Change in functional selectivity of morphine with the development of antinociceptive tolerance. Br J Pharmacol. 2015 Jan; 172(2):549-61.
    View in: PubMed
    Score: 0.227
  5. Bobeck EN, Chen Q, Morgan MM, Ingram SL. Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance. Neuropsychopharmacology. 2014 Aug; 39(9):2142-52.
    View in: PubMed
    Score: 0.222
  6. Ingram SL, Traynor JR. Role of protein kinase C in functional selectivity for desensitization at the mu-opioid receptor: from pharmacological curiosity to therapeutic potential. Br J Pharmacol. 2009 Sep; 158(1):154-6.
    View in: PubMed
    Score: 0.162
  7. Ingram SL, Macey TA, Fossum EN, Morgan MM. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists. Neuropsychopharmacology. 2008 Sep; 33(10):2494-504.
    View in: PubMed
    Score: 0.144
  8. Morgan MM, Fossum EN, Levine CS, Ingram SL. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol Biochem Behav. 2006 Sep; 85(1):214-9.
    View in: PubMed
    Score: 0.132
  9. Morgan MM, Tierney BW, Ingram SL. Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray. Brain Res. 2005 Oct 19; 1059(2):173-8.
    View in: PubMed
    Score: 0.123
  10. Coutens B, Ingram SL. Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics. Neuropharmacology. 2023 03 15; 226:109408.
    View in: PubMed
    Score: 0.102
  11. Sanchez GA, Jutkiewicz EM, Ingram S, Smrcka AV. Coincident Regulation of PLCß Signaling by Gq-Coupled and µ-Opioid Receptors Opposes Opioid-Mediated Antinociception. Mol Pharmacol. 2022 Dec; 102(6):269-279.
    View in: PubMed
    Score: 0.100
  12. Bouchet CA, McPherson KB, Li MH, Traynor JR, Ingram SL. Mice Expressing Regulators of G protein Signaling-insensitive Gao Define Roles of µ Opioid Receptor Gao and Gai Subunit Coupling in Inhibition of Presynaptic GABA Release. Mol Pharmacol. 2021 09; 100(3):217-223.
    View in: PubMed
    Score: 0.092
  13. Ingram SL. Cellular and molecular mechanisms of opioid action. Prog Brain Res. 2000; 129:483-92.
    View in: PubMed
    Score: 0.083
  14. Bobeck EN, Schoo SM, Ingram SL, Morgan MM. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats. J Pain. 2019 09; 20(9):1040-1047.
    View in: PubMed
    Score: 0.078
  15. Bobeck EN, Ingram SL, Hermes SM, Aicher SA, Morgan MM. Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance. Behav Brain Res. 2016 Feb 01; 298(Pt B):17-24.
    View in: PubMed
    Score: 0.062
  16. Li MH, Suchland KL, Ingram SL. GABAergic transmission and enhanced modulation by opioids and endocannabinoids in adult rat rostral ventromedial medulla. J Physiol. 2015 Jan 01; 593(1):217-30.
    View in: PubMed
    Score: 0.058
  17. Mehalick ML, Ingram SL, Aicher SA, Morgan MM. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat. J Pain. 2013 Dec; 14(12):1601-10.
    View in: PubMed
    Score: 0.054
  18. Lamberts JT, Smith CE, Li MH, Ingram SL, Neubig RR, Traynor JR. Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gao protein. J Neurosci. 2013 Mar 06; 33(10):4369-77.
    View in: PubMed
    Score: 0.052
  19. Bobeck EN, Haseman RA, Hong D, Ingram SL, Morgan MM. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat. J Pain. 2012 Aug; 13(8):799-807.
    View in: PubMed
    Score: 0.049
  20. Macey TA, Ingram SL, Bobeck EN, Hegarty DM, Aicher SA, Arttamangkul S, Morgan MM. Opioid receptor internalization contributes to dermorphin-mediated antinociception. Neuroscience. 2010 Jun 30; 168(2):543-50.
    View in: PubMed
    Score: 0.042
  21. Macey TA, Bobeck EN, Hegarty DM, Aicher SA, Ingram SL, Morgan MM. Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat. J Pharmacol Exp Ther. 2009 Nov; 331(2):412-8.
    View in: PubMed
    Score: 0.040
  22. Morgan MM, Bobeck EN, Ingram SL. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res. 2009 Oct 27; 1295:59-66.
    View in: PubMed
    Score: 0.040
  23. Meyer PJ, Morgan MM, Kozell LB, Ingram SL. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology (Berl). 2009 Jun; 204(3):531-40.
    View in: PubMed
    Score: 0.039
  24. Fossum EN, Lisowski MJ, Macey TA, Ingram SL, Morgan MM. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception. Brain Res. 2008 Apr 14; 1204:53-8.
    View in: PubMed
    Score: 0.036
  25. Meyer PJ, Fossum EN, Ingram SL, Morgan MM. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology. 2007 Jun; 52(8):1580-5.
    View in: PubMed
    Score: 0.034
  26. Kandasamy R, Hillhouse TM, Livingston KE, Kochan KE, Meurice C, Eans SO, Li MH, White AD, Roques BP, McLaughlin JP, Ingram SL, Burford NT, Alt A, Traynor JR. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects. Proc Natl Acad Sci U S A. 2021 04 20; 118(16).
    View in: PubMed
    Score: 0.023
  27. Christie MJ, Connor M, Vaughan CW, Ingram SL, Bagley EE. Cellular actions of opioids and other analgesics: implications for synergism in pain relief. Clin Exp Pharmacol Physiol. 2000 Jul; 27(7):520-3.
    View in: PubMed
    Score: 0.021
  28. Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Regulation of µ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013 Jan; 65(1):223-54.
    View in: PubMed
    Score: 0.013
  29. Cyr MC, Ingram SL, Aicher SA, Morgan MM. Chronic psychostimulant exposure to adult, but not periadolescent rats reduces subsequent morphine antinociception. Pharmacol Biochem Behav. 2012 Jun; 101(4):538-43.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)